Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 106, Issue 8, Pages 1008-1015
Publisher
Wiley
Online
2015-05-30
DOI
10.1111/cas.12705
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1
- (2014) Georgios Pantouris et al. AMINO ACIDS
- Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APCMin/+ mice
- (2014) Paulina Akeus et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
- (2014) E. Pastille et al. CANCER RESEARCH
- Blockade of Indoleamine 2,3-Dioxygenase Reduces Mortality from Peritonitis and Sepsis in Mice by Regulating Functions of CD11b+Peritoneal Cells
- (2014) Masato Hoshi et al. INFECTION AND IMMUNITY
- IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
- (2014) Richard Metz et al. INTERNATIONAL IMMUNOLOGY
- The Indoleamine 2,3-Dioxygenase Pathway Is Essential for Human Plasmacytoid Dendritic Cell-Induced Adaptive T Regulatory Cell Generation
- (2014) W. Chen et al. JOURNAL OF IMMUNOLOGY
- IDO1 Metabolites Activate β-catenin Signaling to Promote Cancer Cell Proliferation and Colon Tumorigenesis in Mice
- (2013) Ameet I. Thaker et al. GASTROENTEROLOGY
- IDO1 Plays an Immunosuppressive Role in 2,4,6-Trinitrobenzene Sulfate-Induced Colitis in Mice
- (2013) M. Takamatsu et al. JOURNAL OF IMMUNOLOGY
- Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase
- (2012) Mee Young Chang et al. CANCER BIOLOGY & THERAPY
- CD25+ T cell depletion impairs murine squamous cell carcinoma development via modulation of antitumor immune responses
- (2012) R. N. Ramos et al. CARCINOGENESIS
- IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
- (2012) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Indoleamine 2,3-dioxygenase expression in human inflammatory bowel disease
- (2012) Liping Zhou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Inflammation and colorectal cancer: colitis-associated neoplasia
- (2012) Sergei I. Grivennikov Seminars in Immunopathology
- Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer
- (2011) L Ferdinande et al. BRITISH JOURNAL OF CANCER
- Upregulated Expression of Indoleamine 2, 3-Dioxygenase in Primary Breast Cancer Correlates with Increase of Infiltrated Regulatory T CellsIn Situand Lymph Node Metastasis
- (2011) Jinpu Yu et al. Clinical & Developmental Immunology
- The Indoleamine-2,3-Dioxygenase (IDO) Inhibitor 1-Methyl-D-tryptophan Upregulates IDO1 in Human Cancer Cells
- (2011) Christiane A. Opitz et al. PLoS One
- Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2
- (2010) Christopher Jonathan Daraius Austin et al. AMINO ACIDS
- Genetic ablation of Tnfα demonstrates no detectable suppressive effect on inflammation-related mouse colon tumorigenesis
- (2010) Hiroyasu Sakai et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction
- (2010) G. Matteoli et al. GUT
- Induction of IDO-1 by Immunostimulatory DNA Limits Severity of Experimental Colitis
- (2010) M. A. Ciorba et al. JOURNAL OF IMMUNOLOGY
- The Absence of IDO Upregulates Type I IFN Production, Resulting in Suppression of Viral Replication in the Retrovirus-Infected Mouse
- (2010) M. Hoshi et al. JOURNAL OF IMMUNOLOGY
- The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
- (2009) Yan-Fang Gao et al. Journal of Translational Medicine
- IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
- (2008) Stefan Löb et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway
- (2008) Helen J. Ball et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
- (2008) Ke Pan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now